Evoke Pharma Inc (EVOK)
0.55
+0.07
(+14.58%)
USD |
NASDAQ |
May 02, 16:00
0.55
0.00 (0.00%)
After-Hours: 20:00
Evoke Pharma Revenue (Quarterly): 1.676M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.676M |
| September 30, 2023 | 1.563M |
| June 30, 2023 | 1.131M |
| March 31, 2023 | 0.8104M |
| December 31, 2022 | 0.7964M |
| September 30, 2022 | 0.8321M |
| June 30, 2022 | 0.4618M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.4184M |
| December 31, 2021 | 0.3606M |
| September 30, 2021 | 0.9304M |
| June 30, 2021 | 0.2366M |
| March 31, 2021 | 0.0904M |
| December 31, 2020 | 0.023M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.023M
Minimum
Dec 2020
1.676M
Maximum
Dec 2023
0.7177M
Average
0.7964M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
| Eton Pharmaceuticals Inc | 7.313M |
| NovaBay Pharmaceuticals Inc | 3.727M |
| Palatin Technologies Inc | 2.034M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.987M |
| Total Expenses (Quarterly) | 3.564M |
| EPS Diluted (Quarterly) | -0.59 |
| Enterprise Value | 4.923M |
| Gross Profit Margin (Quarterly) | 96.48% |
| Profit Margin (Quarterly) | -118.6% |
| Earnings Yield | -423.6% |
| Normalized Earnings Yield | -423.64 |